Biointelect offers consulting services for biopharmaceutical entities looking to commercialise new technologies to support an effective market entry strategy.
Sydney, New South Wales
Joined October 2015
- Tweets51
- Following158
- Followers170
- Likes130
💡 Ready to take your idea to the next level but wondering how to fund it? 💡
Register now for the Biointelect Venturer Program!
arcs.com.au/events/venturer-…
The 2023 courses will be held across 5 states, with the first in Adelaide on Thursday 16th February.
Biointelect retweeted
NOVAVAX APPROVED: Nuvaxovid is the first protein-based COVID-19 vaccine registered for use as a booster in Australia.
Novavax, Inc today announced the TGA has granted provisional registration of the Nuvaxovid COVID-19 vaccine as a booster in individuals aged 18 and over. #9News
Biointelect retweeted
Novavax will be giving six different presentations showcasing our vaccine data at Australia's Communicable Diseases & Immunisation Conference, #CDIC2022. Learn more: bit.ly/3Hug1IZ
Biointelect retweeted
This next episode we discuss with Jennifer Herz from #Biointelect how she and Karl Herz from #Biocelect established their #relationship with @novavax leading to Biocelect being their sponsor for the #covid19vaccine in Australia and New Zealand
Congratulations to the Novavax and Biocelect team for this milestone ir.novavax.com/2021-10-29-No…
Come and meet the @BiointelectInfo team at booth 33 at the @ARCSAustralia 2021 conference #arcsaus #commercialisation
Proof that you don’t need hundreds of people or large hospital trusts to recruit for large scale studies. This team of dedicated, wonderful NHS staff has now randomised 638 people to the @Novavax Phase 3 vaccine study and we’re not stopping there. #nextstop650
Congratulations @novavax
This morning, we were pleased to announce the signing of a Heads of Terms agreement with the Australian Government for our #COVID #vaccine. Please read our announcement for details: bit.ly/2I14PJ6 #vaccine $NVAX #australia
Great panel discussion just now at @MTPConnect_AUS launch of @AAMRNet_ . @BiointelectInfo can support your business case, project management, grant writing as well as market access strategy for Antimicrobials
Great news for @Novavax and for Australia to have this phase 1 trial starting in Melbourne abc supported by @TheNucleusNet and @360biolabs
$NVAX is very excited to have just announced initiation of the #phase1 portion of the Phase 1/2 clinical trial for #NVXCoV2373, our #COVID19 #vaccine . Read our news release to learn more to learn more at ir.novavax.com/news-releases…. #novavax2020
Congratulations to Biocelect for the launch of their first product !
1st Shipment of Kodatef (tafenoquine succinate) for Malaria Prophylaxis arrives in Sydney linkedin.com/pulse/1st-shipm…
1st Shipment of Kodatef (tafenoquine succinate) for Malaria Prophylaxis arrives in Sydney linkedin.com/pulse/1st-shipm…
Biointelect retweeted
In this week of #ICYMI - we feature activities from our CEO @DrDanGrant, our GM Stakeholder Engagement Dr Alfredo Martinez-Coll and our Director Major Projects @ElizabethStares mtpconnect.org.au/Story?Acti…
Encouraging #cancer patients and patient organisations to have their say about funding of new treatments - please complete our survey if you are interested lnkd.in/frTuhfE
Biocelect announced today the Australian approval of KODATEF (tafenoquine) tablets for the prevention of malaria in adults, first TGA approval for a new drug for the prevention of malaria in 20 years - congrats
US Food and Drug Administration Approves ARAKODA™ (tafenoquine) tablets for oral use; First preventative antimalarial approved in almost two decades linkedin.com/pulse/us-food-d…
#Bioshares2018 - great meeting, so nice to hear the human stories that back up the science and commerce and meet so many interesting people - we’ll be back